tiprankstipranks
Trending News
More News >
Infant Bacterial Therapeutics AB (DE:9IB)
FRANKFURT:9IB

Infant Bacterial Therapeutics AB (9IB) Revenue

Compare
4 Followers

Infant Bacterial Therapeutics AB Revenue

Infant Bacterial Therapeutics AB had a revenue of 0.00 in the quarter ending Jun 30, 2025, with ―. This bring the company's revenue in the last twelve months to -1.00K, Decreased 0.00%. In the fiscal year ending Dec 31, 2024, Infant Bacterial Therapeutics AB had annual revenue of 4.00K with -94.81% growth.
Revenue (ttm)
-1.00K
Revenue Growth
P/S Ratio
15418.28
Revenue/Employee
€500
Employees
8
Market Cap
€61.67M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
4.00K-73.00K-94.81%
Dec 31, 2023
77.00K65.00K+541.67%
Dec 31, 2022
12.00K+∞%
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
-238.00K-100.00%
Dec 31, 2017
238.00K